Initial Observations on the COVID-19 Pandemic

A regional health plan sought to migrate to a new CRM platform as part of a multi-year technology transformation aimed at better servicing its members. This CRM is used by roughly a third of the client’s employees to document and manage tens of thousands of customer interactions a year.

A Global Medical Affairs infectious disease team wanted to understand and leverage key learnings from Disease Awareness pre-launch/launch activities of relevant analog vaccines to inform a global strategy for a vaccine in clinical development. Learn more about how Vynamic approached and delivered this project.

The COVID-19 pandemic has changed how new therapies are commercially launched in the US, and many life sciences manufacturers have had to pivot to ensure patients are able to access medications they need. Learn how Vynamic recently advised two large pharmaceutical companies working within in an alliance on how to pivot their launch planning efforts (both internally and externally) for two oncology indication launches.